{
  "version": "1.0",
  "description": "Tier 2 ClinVar→dosing heuristic rules for non-CPIC variants",
  "last_updated": "2025-01-04",
  "rules": [
    {
      "rule_id": "RULE_1",
      "name": "Strong Pathogenic Consensus",
      "description": "≥3 Pathogenic/Likely Pathogenic submissions with no Benign submissions",
      "condition": {
        "pathogenic_count": ">= 3",
        "likely_pathogenic_count": ">= 0",
        "benign_count": "== 0",
        "likely_benign_count": "== 0"
      },
      "recommendation": "REDUCE_50",
      "adjustment_factor": 0.5,
      "rationale": "Strong consensus for pathogenicity from multiple independent labs",
      "confidence": "HIGH",
      "flag_for_review": false
    },
    {
      "rule_id": "RULE_2",
      "name": "Very Strong Pathogenic (with conflicts)",
      "description": "≥5 Pathogenic submissions even if conflicts exist",
      "condition": {
        "pathogenic_count": ">= 5",
        "total_pathogenic_likely_pathogenic": ">= 5"
      },
      "recommendation": "REDUCE_50_FLAG",
      "adjustment_factor": 0.5,
      "rationale": "Very strong pathogenic signal (≥5 submissions) warrants dose reduction despite conflicts",
      "confidence": "HIGH",
      "flag_for_review": true,
      "flag_reason": "Conflicting interpretations present but strong pathogenic consensus"
    },
    {
      "rule_id": "RULE_3",
      "name": "Conflicting Evidence",
      "description": "2 Pathogenic + ≥2 Benign submissions",
      "condition": {
        "pathogenic_count": "== 2",
        "benign_count": ">= 2",
        "total_pathogenic_likely_pathogenic": ">= 2",
        "total_benign_likely_benign": ">= 2"
      },
      "recommendation": "FLAG_FOR_EXPERT_REVIEW",
      "adjustment_factor": null,
      "rationale": "Conflicting evidence requires expert clinical judgment",
      "confidence": "LOW",
      "flag_for_review": true,
      "flag_reason": "Conflicting pathogenicity interpretations"
    },
    {
      "rule_id": "RULE_4",
      "name": "Single Pathogenic Submission",
      "description": "Only 1 Pathogenic submission (no consensus)",
      "condition": {
        "pathogenic_count": "== 1",
        "likely_pathogenic_count": "== 0",
        "total_pathogenic_likely_pathogenic": "== 1"
      },
      "recommendation": "SURFACE_EVIDENCE_ONLY",
      "adjustment_factor": null,
      "rationale": "Insufficient evidence for dosing change (single submission)",
      "confidence": "VERY_LOW",
      "flag_for_review": false,
      "note": "No dosing adjustment recommended; evidence surfaced for clinician awareness"
    },
    {
      "rule_id": "RULE_5",
      "name": "Benign Consensus",
      "description": "≥3 Benign/Likely Benign submissions with no Pathogenic submissions",
      "condition": {
        "benign_count": ">= 3",
        "likely_benign_count": ">= 0",
        "pathogenic_count": "== 0",
        "likely_pathogenic_count": "== 0"
      },
      "recommendation": "NO_ACTION",
      "adjustment_factor": 1.0,
      "rationale": "Strong consensus for benign variant",
      "confidence": "HIGH",
      "flag_for_review": false
    },
    {
      "rule_id": "RULE_6",
      "name": "VUS Only",
      "description": "Only VUS (Uncertain Significance) submissions, no Pathogenic or Benign",
      "condition": {
        "vus_count": ">= 1",
        "pathogenic_count": "== 0",
        "likely_pathogenic_count": "== 0",
        "benign_count": "== 0",
        "likely_benign_count": "== 0"
      },
      "recommendation": "SURFACE_EVIDENCE_ONLY",
      "adjustment_factor": null,
      "rationale": "VUS status provides no actionable dosing guidance",
      "confidence": "VERY_LOW",
      "flag_for_review": false,
      "note": "No dosing adjustment recommended; VUS status surfaced for clinician awareness"
    },
    {
      "rule_id": "RULE_7",
      "name": "Moderate Pathogenic (2 submissions)",
      "description": "2 Pathogenic/Likely Pathogenic submissions with no Benign",
      "condition": {
        "total_pathogenic_likely_pathogenic": "== 2",
        "total_benign_likely_benign": "== 0",
        "pathogenic_count": ">= 1"
      },
      "recommendation": "REDUCE_25_FLAG",
      "adjustment_factor": 0.75,
      "rationale": "Moderate pathogenic signal (2 submissions) warrants conservative dose reduction",
      "confidence": "MODERATE",
      "flag_for_review": true,
      "flag_reason": "Limited evidence (2 submissions) - consider expert review"
    }
  ],
  "evaluation_criteria": {
    "true_positive": {
      "definition": "System recommended 'REDUCE_50' or 'REDUCE_25_FLAG' AND patient had Grade 3-5 toxicity",
      "examples": ["REDUCE_50 + Grade 4 neutropenia", "REDUCE_25_FLAG + Grade 3 mucositis"]
    },
    "true_negative": {
      "definition": "System recommended 'NO_ACTION' or 'SURFACE_EVIDENCE_ONLY' AND patient had Grade 0-2 or no toxicity",
      "examples": ["NO_ACTION + Grade 1 toxicity", "SURFACE_EVIDENCE_ONLY + no toxicity"]
    },
    "false_positive": {
      "definition": "System recommended 'REDUCE_50' or 'REDUCE_25_FLAG' BUT patient had Grade 0-2 or no toxicity",
      "examples": ["REDUCE_50 + Grade 1 toxicity", "REDUCE_25_FLAG + no toxicity"]
    },
    "false_negative": {
      "definition": "System recommended 'NO_ACTION' or 'SURFACE_EVIDENCE_ONLY' BUT patient had Grade 3-5 toxicity",
      "examples": ["NO_ACTION + Grade 4 toxicity", "SURFACE_EVIDENCE_ONLY + Grade 5 (fatal)"]
    },
    "indeterminate": {
      "definition": "System recommended 'FLAG_FOR_EXPERT_REVIEW' - cannot be scored as TP/TN/FP/FN",
      "note": "These cases should be analyzed separately"
    }
  },
  "toxicity_grading": {
    "positive_outcome": [3, 4, 5],
    "negative_outcome": [0, 1, 2],
    "grade_5_definition": "Fatal toxicity"
  },
  "notes": [
    "These rules are heuristic and require clinical validation",
    "Rules prioritize safety (conservative approach)",
    "FLAG recommendations require expert clinical judgment",
    "SURFACE_EVIDENCE_ONLY means no dosing change but evidence is presented to clinician"
  ]
}









